New Risk Assessment Tool Could Enhance Ovarian Cancer Detection
The tool uses results from the CA125 blood test along with a woman's age to generate a personalized risk score for ovarian cancer.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
Non-invasive Prenatal Testing Service Launched
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Womens Health
Latest
Two Genes Identified that Link Rheumatoid Arthritis and Osteoporosis
Researchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Researchers Explore Emerging Solutions for Early Endometriosis Diagnosis
Endometriosis affects over 11% of women and remains challenging to diagnose early, with researchers exploring new diagnostic methods.
Read More
Prenatal Exposure Syndromes Can be Accurately Diagnosed
Researchers are using advanced AI technology, EpiSign, to diagnose rare genetic diseases and prenatal exposure-related birth abnormalities.
Read More
Prenatal Genetic Screening Won’t Lead to ‘Designer Babies’
Gattaca Genomics aims to enhance family-building through advanced prenatal genetic screening, increasing the success rates and access.
Read More
Home Test Reveals Risk of Heart Attack in Five Minutes
A new home-based questionnaire can identify individuals at high risk of heart attacks with the same accuracy as clinical blood tests.
Read More
Cell-Based Non-Invasive Prenatal Test Uses Simple Maternal Blood Draw
Menarini Silicon Biosystems presented a study, about its advanced non-invasive prenatal testing technology using maternal blood.
Read More
Blood Test Can Help Predict Risk of Sleep Apnea
Measuring blood levels of homocysteine can help predict the risk and progression of obstructive sleep apnea.
Read More
Better Congenital CMV Screening Needs More Awareness, Legislative Action
Recent advancements in congenital CMV (cCMV) screening underscore the need for enhanced awareness and legislative action.
Read More
New Test Rapidly Diagnoses Toxoplasma Infection
The test monitors pregnant women for Toxoplasma gondii infections, and detects infections within 30 minutes from a finger-prick.
Read More
Accounting for Self-Reported Race in Prenatal Screening Is Vital
Labs should consider self-reported race when screening for open neural tube defects to improve prenatal care equity for Black individuals.
Read More
First Trimester Screening Test Assesses Preeclampsia Risk
Labcorp has introduced a first trimester preeclampsia screening test to assess preeclampsia risk between 11- and 14-weeks’ gestation.
Read More
PinkDX to Develop Diagnostics that Address Women’s Unmet Medical Needs
PinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.Â
Read More
How New Machine Learning Models Can Help Diagnose Women’s Heart Disease
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read More
Making the Case for New Biomarker-based Assays
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read More
Agilent’s Postnatal Assay Gets European IVDR Class C Certification
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read More
Siemens’ New Reproductive Assay to Help Guide In Vitro Fertilization
The AMH Assay can support a lab’s reproductive endocrinology test menu as it aids a physician’s assessment of initiating IVF with a patient.
Read More